What Is Our Common Purpose?

Transcription

1 Imperial Health Sciences In Africa

2 What Is Our Common Purpose? To Support Secure and Sustainable Access To Quality Medicines For The People Of Africa! Our Brand dstatementt t Africa s leading partner in healthcare supply chain Our Brand Positioning Africa Healthcare Supply Chain IHS

3 Imperial Health Sciences Who we are A single brand facing the market by product Sectors Specialisation Service excellence Providing services across the value chain Growth into Africa Sectors Geographies Pharma Consumer Health Geographies SADC Kenya, Tanz, Uganda Ghana & Nigeria

4 Imperial Health Sciences Cont. P = Position Shared Solution Channel access Quality Of service Of systems Cost To Serve e Tool Box Solution CONTRACT Defined Closed Solution Profit thru consolidation Contract Parameters (geography and channel dependent)

5 IHS Coverage & Services Inventory Consignment Pre Wholesaling Model Provides end to end supply chain solutions including: Inbound Freight Management Warehousing Order Management Secondary Repackaging Kitting Outbound Distribution Customer Services 3 rd Party Invoicing ( Back2Back ) Debtor Management Reverse Logistics Cold Chain Management

6 THE OPPORTUNITY OF AFRICA Mature markets CAGR Examining our paradigm 1,000 20% US 0-3% The time for Africa is NOW! Japan 2-5% 800 Commercial capacity is growing 15% Germany 1-4% 600 Private healthcare delivery is growing France 0-3% 10% Italy 1-4% PPPs are de rigeur m diabetics 1m new cancer pts pa Value Sales (LCUS $ bn) 1,200 Global sales and growth (const. US$) 25% Value Growth % (LCUS $) Canada -2-1% Spain 1-4% UK -1-2% - 0% 60m hypertensives F 2012F 2013F 2014F 2015F Mature 1-4% Gauteng = 12% of SSA GDP Emerging transport corridors % growth in urban pop 34%pa 3.4% 2030 >60yrs population doubles % urbanised Value for Many Value for Many replaces Value for Money 200 Global USA EU5 Japan Tier 1 Pharmerging Tier 2 Pharmerging Tier 3 Pharmerging 5%

7 Supporting Client Business Growth POPULAT TION CURV VE PAP 2 PAP 1 PAP = PRODUCT AFFORDABILITY POINT End to end supply chain solutions: Inbound Freight Management Warehousing & Quality Management Order Management Repackaging & Kitting Outbound Distribution Reverse Logistics Cold Chain Management Flexible Commercial Options Consignment OR Trading Pre Wholesaling OR Direct 3 rd Party Invoicing ( SPM ) Client A: Opened the market to 7 distributors in Kenya (from 1) Increased FOB price by 50% and 44% price reduction to the patients Moved from quarterly to weekly orders Tripled the sales in region and doubled the sales of the initial distributor Old IHS Commercial Integrated Supply model Chain Imperial Health Sciences 7

8 MMWs A Game Changer For All Parties VALUE TO MANUFACTURER VALUE TO WHOLESALERS S Increased revenue Open multiple channels Chain of custody Price control Quality control Deeper market penetration Higher margin retention Better information demand Decreased lost sales Decreased round tripping & parallel importation Shorter lead times Smaller order sizes More frequent replenishments Improved stock availability Lower working capital

9 Leading & Competing Achieving Growth Where do we win? Debtors IT SAP/ MediQ Customer service CRM Platform to Africa New services? 2 Not 4 Wholesaling Procurement management Demand management International Buy & Sell Labeling & kitting New places? RDC Lusaka LDCs 1ᴼ = own; 2ᴼ = IA (CIC); 3ᴼ = 3 rd party Ethiopia time to plan New people? Hospital groups State NGOs / Donors

10 Tectonic Plates 1 of 2 Generic or innovator Generics Fastest growing segment with double accelerator (patent expiry & market share); NB Needs ABC model and low cost to serve Innovator who is buying and who is being bought? Differentiator is Biotech Ability ie cold chain hi and specialist ilitreach or Both? Absolutely! The State / Public Health Trading on our BBBEE score Demand generation model Requires client input & service model definition ARVs Leverage state service / control tower & DoH GFATM contract to dominate ARV distribution ib ti Mylan / Cipla / Adcock / Aspen Demand management = core

11 Tectonic Plates 2 of 2 Vertical integration Wholesaling Labelling & kitting Development Aid VPP will double PfSCM volumes Need to expand USAID role Need to expand CDC role China syndrome The unknown future Need to understand manufacturers Need to understand donors Air to sea 50% cost reduction Backward integration Enhanced demand management India Inbound No brainer Current estimate > 1,000 12m containers / year Aggregated volumes Regional planning Mode vs need Decrease costs & increase fill rates

12 IHS Southern Africa Region South Africa Centurion Warehouse 26,500 m 2 22,500 pallet spaces 1,100 cold room Transportation Local: own vehicles Export: own & contractors Facility GDP compliant ISO 9001:2008 certified SA s only bonded facility Freight volume = 16,360,329 Kg

13 IHS South Africa, Centurion Facility SOUTH AFRICA - GAUTENG FACILITIES

14 IHS Western Africa Region Ghana a Tema Warehouse 2,300m 2 2,550 pallet spaces 40 cold room 20 dangerous goods High risk / High value area Transportation Export Facility GDP compliant ISO 9001:2008 in Q2 12 Bonded Freight volume = 676,000 Kg Nigeria Abuja Shared facility 930m pallet spaces Freight 250 per month Nigeria Lagos [in planning] MIS SAP, CRM, SLE/TIMS, MEDiQ

15 IHS Ghana, Accra Facility GHANA - TEMA FACILITY

16 IHS Eastern Africa Region Kenya Nairobi Current warehouse 1,860m 2 1,970 pallet spaces 40 cold room 20 dangerous goods High risk / High value area 2014 new WH 15,000m 2 Transportation Local own x2 trucks Ntl / Export contractors Freight volume = 944,738 Kg Facility GDP compliant ISO 9001:2008 certified Freight volume = 944,738 Kg MIS SAP, CRM, SLE / TIMS, MEDiQ

17 IHS Kenya, Nairobi Facility

18 IHS Malawi, Lilongwe Facility

19 IHS Nigeria, Abuja

20 What Is Our Common Purpose? To Ensure The Secure and Sustainable Supply Of Quality Medicines To The People Of Africa! Our Brand dstatementt t Africa s leading partner in healthcare supply chain Our Brand Positioning Africa Healthcare Supply Chain IHS

21 Thank you